BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 31002804)

  • 41. MATE transport of the E. coli-derived genotoxin colibactin.
    Mousa JJ; Yang Y; Tomkovich S; Shima A; Newsome RC; Tripathi P; Oswald E; Bruner SD; Jobin C
    Nat Microbiol; 2016 Jan; 1():15009. PubMed ID: 27571755
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Targeted depletion of
    Blanco-Míguez A; Marcos-Fernández R; Guadamuro-García L; Fdez-Riverola F; Cubiella J; Lourenço A; Margolles A; Sánchez B
    mSystems; 2023 Jun; 8(3):e0007923. PubMed ID: 37219498
    [TBL] [Abstract][Full Text] [Related]  

  • 43. E. coli and colorectal cancer: a complex relationship that deserves a critical mindset.
    Wassenaar TM
    Crit Rev Microbiol; 2018 Sep; 44(5):619-632. PubMed ID: 29909724
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Colibactin Causes Colorectal Cancer-Associated Mutational Signature.
    Cancer Discov; 2020 May; 10(5):635. PubMed ID: 32169880
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Probing Microbiome Genotoxicity: A Stable Colibactin Provides Insight into Structure-Activity Relationships and Facilitates Mechanism of Action Studies.
    Wernke KM; Tirla A; Xue M; Surovtseva YV; Menges FS; Herzon SB
    J Am Chem Soc; 2021 Sep; 143(38):15824-15833. PubMed ID: 34524796
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biosynthesis and bioactivities of microbial genotoxin colibactins.
    Tang JW; Liu X; Ye W; Li ZR; Qian PY
    Nat Prod Rep; 2022 May; 39(5):991-1014. PubMed ID: 35288725
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interplay between siderophores and colibactin genotoxin in Escherichia coli.
    Martin P; Tronnet S; Garcie C; Oswald E
    IUBMB Life; 2017 Jun; 69(6):435-441. PubMed ID: 28295919
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Induction of DNA Damage in Mouse Colorectum by Administration of Colibactin-producing
    Narita T; Tsunematsu Y; Miyoshi N; Komiya M; Hamoya T; Fujii G; Yoshikawa Y; Sato M; Kawanishi M; Sugimura H; Iwashita Y; Totsuka Y; Terasaki M; Watanabe K; Wakabayashi K; Mutoh M
    In Vivo; 2022; 36(2):628-634. PubMed ID: 35241515
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Klebsiella pneumoniae producing bacterial toxin colibactin as a risk of colorectal cancer development - A systematic review.
    Strakova N; Korena K; Karpiskova R
    Toxicon; 2021 Jul; 197():126-135. PubMed ID: 33901549
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ClbS Is a Cyclopropane Hydrolase That Confers Colibactin Resistance.
    Tripathi P; Shine EE; Healy AR; Kim CS; Herzon SB; Bruner SD; Crawford JM
    J Am Chem Soc; 2017 Dec; 139(49):17719-17722. PubMed ID: 29112397
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Insights into evolution and coexistence of the colibactin- and yersiniabactin secondary metabolite determinants in enterobacterial populations.
    Wami H; Wallenstein A; Sauer D; Stoll M; von Bünau R; Oswald E; Müller R; Dobrindt U
    Microb Genom; 2021 Jun; 7(6):. PubMed ID: 34128785
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genomic aberrations after short-term exposure to colibactin-producing E. coli transform primary colon epithelial cells.
    Iftekhar A; Berger H; Bouznad N; Heuberger J; Boccellato F; Dobrindt U; Hermeking H; Sigal M; Meyer TF
    Nat Commun; 2021 Feb; 12(1):1003. PubMed ID: 33579932
    [TBL] [Abstract][Full Text] [Related]  

  • 53. New genotoxin shows diversity of bacterial attack mechanisms.
    Lax AJ
    Trends Mol Med; 2007 Mar; 13(3):91-3. PubMed ID: 17234453
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A commensal-encoded genotoxin drives restriction of
    Chen J; Byun H; Liu R; Jung IJ; Pu Q; Zhu CY; Tanchoco E; Alavi S; Degnan PH; Ma AT; Roggiani M; Beld J; Goulian M; Hsiao A; Zhu J
    Proc Natl Acad Sci U S A; 2022 Mar; 119(11):e2121180119. PubMed ID: 35254905
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interactions between microsatellite instability and human gut colonization by
    Gagnière J; Bonnin V; Jarrousse AS; Cardamone E; Agus A; Uhrhammer N; Sauvanet P; Déchelotte P; Barnich N; Bonnet R; Pezet D; Bonnet M
    Clin Sci (Lond); 2017 Mar; 131(6):471-485. PubMed ID: 28093453
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Structural Basis for the Interactions of the Colibactin Resistance Gene Product ClbS with DNA.
    Tripathi P; Bruner SD
    Biochemistry; 2021 May; 60(20):1619-1625. PubMed ID: 33945270
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Genotoxin Colibactin Is a Determinant of Virulence in Escherichia coli K1 Experimental Neonatal Systemic Infection.
    McCarthy AJ; Martin P; Cloup E; Stabler RA; Oswald E; Taylor PW
    Infect Immun; 2015 Sep; 83(9):3704-11. PubMed ID: 26150540
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Colibactin-producing
    Dalmasso G; Cougnoux A; Faïs T; Bonnin V; Mottet-Auselo B; Nguyen HT; Sauvanet P; Barnich N; Jary M; Pezet D; Delmas J; Bonnet R
    Gut Microbes; 2024; 16(1):2310215. PubMed ID: 38374654
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Advancing the Biosynthetic and Chemical Understanding of the Carcinogenic Risk Factor Colibactin and Its Producers.
    Hirayama Y; Sato M; Watanabe K
    Biochemistry; 2022 Dec; 61(24):2782-2790. PubMed ID: 35723977
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Structure and bioactivity of colibactin.
    Wernke KM; Xue M; Tirla A; Kim CS; Crawford JM; Herzon SB
    Bioorg Med Chem Lett; 2020 Aug; 30(15):127280. PubMed ID: 32527463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.